# Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

> **NCT07173972** · PHASE2 · RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Soft Tissue Sarcoma (STS)
- Soft Tissue Sarcoma Adult
- Soft Tissue Sarcoma of the Trunk and Extremities
- Synovial Sarcomas
- Undifferentiated Pleomorphic Sarcoma (UPS)
- Myxofibrosarcoma
- Leiomyosarcoma (LMS)
- Pleomorphic Liposarcoma
- Pleomorphic Rhabdomyosarcoma
- Liposarcoma

## Interventions

- **RADIATION:** Definitive radiotherapy

## Key facts

- **NCT ID:** NCT07173972
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2029-01-26
- **Final completion:** 2035-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173972, "Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07173972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*